Explore
Premium
Sign Up
Log In
CRT 2017 : FDA Town Hall - Evaluating DES for High-Risk DAPT Patients
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
FDA Town Hall - Evaluating DES for High-Risk DAPT Patients
Featuring
Michael John
Davide Capodanno
Hans-Peter Stoll
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Adjunctive DAPT Labeling for DES – An FDA View - Michael John
Short versus Long DAPT Studies – An Academic View - Davide Capodanno
Study Designs of Short DAPT in the USA – Challenges and Execution of Pivotal Trials - Hans-Peter Stoll
Target Audience
Learning Objectives
Related Moments
CRT 2015 Atherosclerosis & Research - Clinical Trial Organizations
Conference
A session on Clinical Trial Organizations from CRT 2015
CRT 2015 Technology & Innovation - Session IV: Bio-Absorbable Stent
Conference
Session IV: Bio-Absorbable Stent at CRT 2015
CRT 2016 Technology & Innovation - New Preclinical Findings that May Impact Outcome of Renal Denervation
Conference
A session outlining New Preclinical Findings that May Impact Outcome of Renal Denervation
Loading Simple Education
